Talat Imran - 22 Mar 2023 Form 4 Insider Report for Rani Therapeutics Holdings, Inc. (RANI)

Role
CEO, Director
Signature
/s/ Talat Imran
Issuer symbol
RANI
Transactions as of
22 Mar 2023
Transactions value $
-$47,529
Form type
4
Filing time
24 Mar 2023, 16:05:20 UTC
Previous filing
24 Mar 2022
Next filing
29 Mar 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RANI Class A Common Stock Tax liability -$47.5K -7.99K -8.07% $5.95 90.9K 22 Mar 2023 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the number of shares withheld by and surrendered to the Issuer on March 22, 2023, to satisfy tax withholding obligations that arose in connection with the vesting of the restricted stock units granted to Mr. Imran on March 22, 2022.
F2 Includes 12,343 shares held by VH Moll, L.P. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.